Attached files
| file | filename |
|---|---|
| 8-K - DGT Holdings Corp. | form8k05733_11242009.htm |
| EX-10.1 - DGT Holdings Corp. | ex101to8k05733_11242009.htm |
Exhibit 99.1
Del
Global Technologies Announces the Sale of Its Del Medical Imaging Business to
U.M.G., Inc.
ROSELLE,
Ill.--Del Global Technologies
Corp. (OTCBB: DGTC) (“Del Global” or “the
Company”) and UMG, INC. (“UMG”) have completed the transaction to sell certain
assets and the product lines of Del Medical Imaging from Del Global to UMG. The
transfer of ownership was finalized on November 24, 2009. The name of the new
entity is Del Medical, Inc. and will remain at its current location in Roselle,
IL.
“UMG
intends to continue to run Del Medical, Inc. as a wholly-owned subsidiary,
enhance the existing product line and maintain the collective current channels
of distribution. We are proud to bring the Del Medical product lines under the
UMG umbrella. We will continue to offer the same quality and reliability of Del
Medical products that our customers have come to expect. Please visit us at this
years RSNA in the South Hall at Del Booth # 3247 and UMG Booth # 6408.“ says
Toufic Lorenzo, President & CEO of UMG.
“We are
pleased that we have found a home with UMG for the Del Medical U.S. imaging
business that will provide for it to grow and prosper. The transaction does not
include our Villa subsidiary in Italy,” said John Quicke, President and CEO of
Del Global. He added, “Del Global will now focus its efforts on growing
Villa in the international imaging markets and the power supply business through
its RFI business unit. The Company’s headquarters will be moved from Chicago to
RFI’s facility in Bay Shore, NY.”
ABOUT DEL GLOBAL
TECHNOLOGIES
Del
Global Technologies Corp. is primarily engaged in the design, manufacture and
marketing of high performance diagnostic imaging systems for medical and dental
applications through its Milan, Italy based Villa Sistemi Medicali S.p.A.
business. The Company offers a broad portfolio of general radiographic,
radiographic/fluoroscopic, portable x-ray and digital radiographic systems to
the global marketplace. Through its RFI subsidiary, Del Global manufactures
proprietary high-voltage power conversion subsystems including electronic
filters, high voltage capacitors, pulse modulators, transformers and reactors,
and a variety of other products designed for industrial, medical, military and
other commercial applications. The Company’s web site is www.delglobal.com.
ABOUT U.M.G.,
INC.
UMG Inc.,
a privately held company headquartered in Harrison, New York, is a master
distributor of digital and analog medical imaging products to the private
practice, non-hospital, market place. It distributes FujiFilm USA medical x-ray
film and Computed Radiography (CR) systems, Konica-Minolta CR systems, UltraRad
PACS products, and Carestream medical x-ray film to a network of over 350 U.S.
imaging dealers. In addition to its medical products, UMG also private labels
dental x-ray film for major U.S. dental distributors. The company has been
involved in the medical x-ray business since its formation in 1985. Requests for
information regarding UMG Inc. should be directed to info@umgxray.com
Statements
about future results made in this release may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995. These statements are based on current expectations and the current
economic environment. Del Global cautions that these statements are not
guarantees of future performance. These statements involve a number of risks and
uncertainties that are difficult to predict, including, but not limited to: the
ability of Del Global to introduce products as scheduled; obtaining necessary
product certification; implement its business plan; retention of management;
changing industry and competitive conditions; obtaining anticipated operating
efficiencies; securing necessary capital facilities; favorable determinations in
various legal matters; market and operating risks from foreign currency exchange
exposures; and favorable general economic conditions. Actual results could
differ materially from those expressed or implied in the forward-looking
statements. Important assumptions and other important factors that could cause
actual results to differ materially from those in the forward-looking statements
are specified in the Company's filings with the Securities and Exchange
Commission.
Contact:
DEL
GLOBAL TECHNOLOGIES CORP.
John J.
Quicke
Chief
Executive Officer
(847)
288-7065
or
Mark A.
Zorko
Chief
Financial Officer
(847)
288-7003
or
U.M.G.,
Inc.
Toufic
Lorenzo
Chief
Executive Officer
914.835.4600